Teresa Puig Miquel (Teresa Puig)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Prognostic Factors

Cancer Stem Cells

Top Venues

International journal of molecular sciences

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Ros, Gerard Riesco-Llach, Emma Polonio-Alcalá, Pere Miquel Morla-Barcelo, Santiago Ruiz-Martínez, Lidia Feliu, Marta Planas, Teresa Puig Miquel
Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells. International journal of molecular sciences 25 (13) (2024)
Maria Ros, Gerard Riesco-Llach, Emma Polonio-Alcalá, Pere Miquel Morla-Barcelo, Santiago Ruiz-Martínez, Lidia Feliu, Marta Planas, Teresa Puig Miquel
Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells. International journal of molecular sciences 25 (13) (2024)
Emma Polonio-Alcalá, Sònia Solé-Sánchez, Pau Muñoz-Guardiola, Elisabet Megías-Roda, Hector Perez-Montoyo, Marc Yeste-Velasco, Jose Alfón, Jose Miguel Lizcano, Carles Domènech, Santiago Ruiz-Martínez, Teresa Puig Miquel
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models. Cancer communications (London, England) 42 (6) (2022)
Emma Polonio-Alcalá, Marc Rabionet, Santiago Ruiz-Martínez, Sònia Palomeras, Rut Porta, Carmen Vásquez-Dongo, Joaquim Bosch-Barrera, Teresa Puig Miquel, Joaquim Ciurana
Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma. Cancers 13 (21) (2021)
David Angelats Lobo, Paola Ginestra, Elisabetta Ceretti, Teresa Puig Miquel, Joaquim Ciurana
Cancer Cell Direct Bioprinting: A Focused Review. Micromachines 12 (7) (2021)
Emma Polonio-Alcalá, Sònia Palomeras, Daniel Torres-Oteros, Joana Relat, Marta Planas, Lidia Feliu, Joaquim Ciurana, Santiago Ruiz-Martínez, Teresa Puig Miquel
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models. Cancers 12 (5) (2020)